Related Experiment Video
Updated: Jun 16, 2026
04:27
Anterior Capsular Reconstruction with Human Dermal Allograft for Irreparable Subscapularis Tears
Published on: May 9, 2025
Postoperative Outcomes Following Bridging Reconstruction for Large to Massive Rotator Cuff Tears Using Two Different
Abrahim Chidiac1, Aleksandra Budarick2, Jiaxin Hu2
1Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Orthopaedic Journal of Sports Medicine
|June 15, 2026
Summary
GraftJacket and AlloPatch allografts show similar healing and patient outcomes for large rotator cuff tears. This study found comparable efficacy between these two acellular dermal scaffolds in bridging reconstructions.
Area of Science:
- Orthopedic surgery
- Regenerative medicine
- Biomaterials science
Background:
- Rotator cuff tears, especially large ones, often lead to poor outcomes and retears after surgical repair.
- Acellular dermal allografts like GraftJacket and AlloPatch provide a scaffold to support healing and improve structural integrity in rotator cuff reconstruction.
- Comparative clinical data on GraftJacket and AlloPatch for rotator cuff repair are limited, despite similar biomechanical properties.
Purpose of the Study:
- To compare the radiologic and clinical outcomes of arthroscopic rotator cuff reconstruction using GraftJacket versus AlloPatch allografts.
- To evaluate graft healing, patient-reported outcomes, and structural integrity after bridging reconstruction for large to massive rotator cuff tears.
Main Methods:
- A cohort study (Level of evidence, 3) included patients with large to massive rotator cuff tears (>3 cm) undergoing arthroscopic bridging reconstruction with GraftJacket or AlloPatch.
- Primary outcome was graft healing via MRI; secondary outcome was the Western Ontario Rotator Cuff (WORC) index.
- Tertiary outcomes included acromiohumeral interval (AHI), muscle atrophy, fatty infiltration, and structural integrity (Sugaya classification).
Main Results:
- No significant demographic differences were observed between the GraftJacket (n=49) and AlloPatch (n=37) groups.
- Graft healing rates were similar (AlloPatch: 76%, GraftJacket: 69%; P=.52).
- Both groups showed significant improvement in WORC scores, with no between-group difference (P=.97); AlloPatch showed increased postoperative AHI, while GraftJacket had higher postoperative structural integrity.
Conclusions:
- GraftJacket and AlloPatch dermal allografts demonstrate comparable efficacy in arthroscopic bridging reconstruction for large to massive rotator cuff tears.
- Both allografts yield similar graft healing rates, patient-reported outcomes (WORC index), and structural imaging metrics.
- The study suggests similar clinical effectiveness between GraftJacket and AlloPatch for this patient population.
